ClinVar Miner

Submissions for variant NM_005921.2(MAP3K1):c.566T>C (p.Leu189Pro)

dbSNP: rs387906788
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Preventiongenetics, part of Exact Sciences RCV003407356 SCV004109625 pathogenic MAP3K1-related condition 2023-05-30 criteria provided, single submitter clinical testing The MAP3K1 c.566T>C variant is predicted to result in the amino acid substitution p.Leu189Pro. This variant has been previously reported in an individual with 46,XY complete gonadal dysgenesis (Pearlman et al. 2010. PubMed ID: 21129722). Functional studies support its pathogenicity (Loke and Ostrer. 2012. PubMed ID: 22171599; Upadhyay et al. 2018. PubMed ID: 29095481; Chamberlin et al. 2019. PubMed ID: 30608580). Alternative nucleotide changes affecting the same amino acid (p.Leu189Arg and p.Leu189Gln) have also been reported in unrelated individuals with disorders of sex development (Pearlman et al. 2010. PubMed ID: 21129722; Granados et al. 2017. PubMed ID: 28504475). The c.566T>C (p.Leu189Pro) variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. In summary, this variant is interpreted as pathogenic.
OMIM RCV000023057 SCV000044348 pathogenic 46,XY sex reversal 6 2010-12-10 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.